Home › Learn › Appetite Signals

The Maintenance Phase

Appetite signals after GLP-1: what returns and when

Hunger doesn't switch back on the day after your last injection — it returns gradually as the medication clears your system. Knowing roughly what to expect, and which early signals to watch for, can help you and your provider stay ahead of the changes.

Why the return is gradual, not sudden

Injectable GLP-1 medications leave the body slowly. Depending on the specific medication, it can take several weeks for levels to fall substantially after a final dose. Because the appetite-suppressing effect fades along with those levels, most people describe hunger creeping back over weeks rather than arriving overnight. The exact timeline is individual — it depends on the medication, your dose, how long you were treated, and your own physiology — so treat any schedule below as a general pattern, not a promise.

A general timeline of what many patients report

• First one to two weeks: Some people notice little change at first, since medication levels are still meaningful. Others report that meals start to feel slightly less filling toward the end of this window.
• Weeks two to four: This is when many patients commonly describe hunger becoming more noticeable — thinking about food more often, feeling less satisfied after a normal portion, and reaching for snacks sooner between meals.
• Weeks four to eight: As medication levels drop further, appetite for many returns toward pre-treatment levels. Cravings, particularly for sugar and refined carbohydrates, are frequently reported around this stage.
• Beyond two months: For many, appetite signaling has largely returned to where their baseline biology sets it. This is often when weight regain, if it happens, becomes visible.

Early warning signs worth noticing

Changes in appetite usually show up before changes on the scale. Common early signals that patients report include:

• Feeling hungry again within a couple of hours of a meal that used to hold you longer.
• Thinking about food more frequently, or noticing "food noise" — background mental chatter about eating — returning.
• Larger portions feeling normal again, or finishing a plate you would have left half-full on medication.
• Specific cravings, especially for sweets, resurfacing first.

None of these mean anything has gone wrong. They're the expected result of appetite hormones returning after the medication that quieted them is gone. Noticing them early simply gives you time to respond.

What to do with the early signals

The most useful thing you can do is treat returning appetite as information rather than a setback. Bring it to a licensed provider, ideally before you finish your injections rather than after. A clinician can help you weigh nutrition and activity strategies, ongoing check-ins, and — for some eligible patients — continued medication support in a different form. Needle-free, prescription-only options such as THIN™, a compounded semaglutide sublingual spray, exist specifically for this maintenance phase and are dispensed only if a licensed provider determines they are appropriate. THIN™ is not FDA-approved.

If you're weighing your next step, a short eligibility check is a free, no-pressure way to see whether a provider conversation makes sense.